Wells Fargo’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $228M | Sell |
|
|||||
|
2025
Q2 | $288M | Buy |
|
|||||
|
2025
Q1 | $263M | Buy |
|
|||||
|
2024
Q4 | $316M | Sell |
|
|||||
|
2024
Q3 | $484M | Sell |
|
|||||
|
2024
Q2 | $583M | Buy |
|
|||||
|
2024
Q1 | $508M | Buy |
|
|||||
|
2023
Q4 | $393M | Buy |
|
|||||
|
2023
Q3 | $334M | Buy |
|
|||||
|
2023
Q2 | $270M | Buy |
|
|||||
|
2023
Q1 | $253M | Sell |
|
|||||
|
2022
Q4 | $217M | Sell |
|
|||||
|
2022
Q3 | $160M | Sell |
|
|||||
|
2022
Q2 | $199M | Buy |
|
|||||
|
2022
Q1 | $188M | Buy |
|
|||||
|
2021
Q4 | $170M | Sell |
|
|||||
|
2021
Q3 | $148M | Buy |
|
|||||
|
2021
Q2 | $128M | Sell |
|
|||||
|
2021
Q1 | $119M | Buy |
|
|||||
|
2020
Q4 | $116M | Buy |
|
|||||
|
2020
Q3 | $112M | Buy |
|
|||||
|
2020
Q2 | $93.9M | Sell |
|
|||||
|
2020
Q1 | $86.9M | Buy |
|
|||||
|
2019
Q4 | $82.3M | Sell |
|
|||||
|
2019
Q3 | $74M | Buy |
|
|||||
|
2019
Q2 | $72.5M | Buy |
|
|||||
|
2019
Q1 | $72.8M | Buy |
|
|||||
|
2018
Q4 | $59.4M | Sell |
|
|||||
|
2018
Q3 | $63.4M | Buy |
|
|||||
|
2018
Q2 | $60M | Buy |
|
|||||
|
2018
Q1 | $56.3M | Sell |
|
|||||
|
2017
Q4 | $71.6M | Sell |
|
|||||
|
2017
Q3 | $64.3M | Sell |
|
|||||
|
2017
Q2 | $65M | Sell |
|
|||||
|
2017
Q1 | $54.5M | Buy |
|
|||||
|
2016
Q4 | $55.8M | Sell |
|
|||||
|
2016
Q3 | $118M | Sell |
|
|||||
|
2016
Q2 | $176M | Buy |
|
|||||
|
2016
Q1 | $92.3M | Sell |
|
|||||
|
2015
Q4 | $101M | Sell |
|
|||||
|
2015
Q3 | $98M | Buy |
|
|||||
|
2015
Q2 | $95M | Buy |
|
|||||
|
2015
Q1 | $89.4M | Buy |
|
|||||
|
2014
Q4 | $68.9M | Sell |
|
|||||
|
2014
Q3 | $92.6M | Sell |
|
|||||
|
2014
Q2 | $93.1M | Buy |
|
|||||
|
2014
Q1 | $88.5M | Sell |
|
|||||
|
2013
Q4 | $84.8M | Buy |
|
|||||
|
2013
Q3 | $59.9M | Buy |
|
|||||
|
2013
Q2 | $51.3M | Buy |
|